Results 61 to 70 of about 12,800 (198)
Haemophilia, EarlyView.ABSTRACT Rare bleeding disorders (RBDs) represent a diverse group of inherited conditions involving coagulation factors or platelets. These conditions, such as Glanzmann thrombasthenia (GT) or severe coagulation factor deficiencies, are uncommon. In contrast, bleeding disorder of unknown cause (BDUC) is a diagnosis of exclusion without an identifiable ...
Alessandro Casini +4 more
wiley +1 more source
Symptoms, Diagnosis, and Treatment for Women and Girls With Hemophilia: A Narrative Review
Haemophilia, EarlyView.ABSTRACT Introduction Hemophilia is an X‐linked bleeding disorder previously thought to present only in men. This sentiment is rapidly changing as the information around women and girls’ experiences of bleeding symptoms has evolved, sparking intense discussion among researchers, clinicians, patients, and patient advocates regarding appropriate ...
Sam Hirniak +6 more
wiley +1 more source
International Brazilian Journal of Urology, 2022 Objectives: The purpose of our study was to assess the association between the winter season and desmopressin treatment failure in South Chinese children with monosymptomatic nocturnal enuresis (MNE).
Mengkui Sun +4 more
doaj +1 more source
Haemophilia, EarlyView.ABSTRACT Introduction Patients with von Willebrand disease (VWD) undergoing surgery require von Willebrand factor (VWF) and factor VIII (FVIII) supplementation for adequate haemostasis. Plasma‐derived clotting factor concentrates differ in their VWF:FVIII activity ratios: high‐ratio product (HRP, 10:1), intermediate‐ratio product (IRP, 2.4:1), and low ...
Zoë A. Gras +2 more
wiley +1 more source
Desmopressin and the risk of hyponatremia: A population-based cohort study.
PLoS Medicine, 2019 BACKGROUND:Desmopressin was approved by the Food and Drug Administration (FDA) in 1978 for use in diabetes insipidus and bleeding disorders, but it is also prescribed off-label for patients with nocturia.
Michael Fralick +4 more
doaj +1 more source
Haemophilia, EarlyView.ABSTRACT Introduction Individuals diagnosed with types 1/1C/2A/2M von Willebrand disease (VWD) typically undergo a desmopressin (DDAVP) challenge to assess therapeutic benefit. This involves measuring von Willebrand factor antigen (VWF:Ag), activity (VWF:Act; VWF:RCo/VWF:GPIbM/VWF:Ab), and coagulant factor VIII (FVIII:C) levels 0 (pre), 1, and 4‐h post‐
Michael Shu +7 more
wiley +1 more source
Desmopressin: a nontransfusional treatment of hemophilia and von Willebrand disease
, 1992 Desmopressin (1-deamino-8-D-arginine vasopressin) is a synthetic analogue of the antidiuretic hormone L-arginine vasopressin. Because it can raise circulating levels of factor VIII and von Willebrand factor, desmopressin is used for nontransfusional ...
M. Cattaneo, P. M. Mannucci
core +1 more source
Risk of Postpartum Hemorrhage in Women With Von Willebrand Disease: A Real‐World Data Analysis
Haemophilia, EarlyView.ABSTRACT Introduction Women with von Willebrand disease (VWD) are at increased risk for postpartum hemorrhage (PPH), but contemporary United States data on maternal outcomes and real‐world peripartum treatment patterns are limited. Aim To evaluate maternal outcomes associated with claims‐recorded VWD in a national claims cohort and describe exploratory
Mayank Patel +4 more
wiley +1 more source
Therapeutic window for desmopressin in noctunal enuresis
, 2022 Title: THERAPEUTIC WINDOW FOR DESMOPRESSIN IN NOCTUNAL ENURESIS Authors: Sevasti Karamaria1,2, Lien Dossche1,2, Ann Raes 1,2, Evelien Snauwaert1, Johan Vande Walle1,2 1Department of Pediatric Nephrology, UZ Gent, Ghent, 2Ghent University ...
Karamaria, Sevasti +4 more
core
Desmopressin Acetate in Intracranial Haemorrhage [PDF]
, 2014 Introduction. The secondary increase in the size of intracranial haematomas as a result of spontaneous haemorrhage or trauma is of particular relevance in the event of prior intake of platelet aggregation inhibitors.
Sabine Struve +6 more
core +1 more source